| Indicators | Browse All

CEL-SCI Corporation (CVM)

Healthcare | Biotechnology | Vienna, United States | NYSE American
1.56 USD -0.04 (-2.500%) ⇩ (Aug. 28, 2026, 4 p.m. EDT)
After hours: 1.63 +0.07 (4.167%) ⇧ (Aug. 28, 2026, 7:55 p.m. EDT)

Short-term:★★☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 2:32 a.m. EDT

The immediate outlook remains deeply bearish as the stock trades significantly below its 50-day moving average, reflecting a persistent lack of near-term momentum despite a recent, volatile bounce. While the price has recovered somewhat from its lows, the underlying business fundamentals are catastrophic: the company is burning cash aggressively with negative free cash flow and operating cash flow, while posting severe losses that result in a negative forward P/E. The balance sheet is fragile, with debt exceeding cash reserves, and the return on equity is deeply negative. Furthermore, the multi-year price trajectory tells a grim story of structural deterioration, with five consecutive years of declining annual returns and a cumulative loss of over 97% since 2016. This extended decline suggests the market has thoroughly priced out the business quality, viewing it as a value trap rather than a bargain. There is no dividend to provide income, and the recent news of equity raises and lock-up expirations adds further pressure on the share price. The statistical forecast offers no relief, predicting a slight downward drift with low confidence. Given the combination of deteriorating fundamentals, a broken balance sheet, and a long-term price collapse, the investment case is non-existent.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.310238
AutoETS0.312695
AutoTheta0.851377
AutoARIMA0.959014

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 30%
H-stat 4.02
Ljung-Box p 0.000
Jarque-Bera p 0.237
Excess Kurtosis -1.23
Attribute Value
Sector Healthcare
Ex Dividend Date 1996-08-27
Debt to Equity Ratio 72.098
Market Cap 27,438,820
Forward P/E -0.24
Beta 0.56
Website https://cel-sci.com

Info Dump

Attribute Value
52 Week Change -0.8684211
Address1 8,229 Boone Boulevard
Address2 Suite 802
All Time High 646,875.0
All Time Low 0.89
Ask 1.62
Ask Size 200
Audit Risk 10
Average Daily Volume10 Day 166,820
Average Daily Volume3 Month 322,546
Average Volume 322,546
Average Volume10Days 166,820
Beta 0.563
Bid 1.56
Bid Size 300
Board Risk 8
Book Value 0.623
City Vienna
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 7
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.56
Current Ratio 1.477
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 1.61
Day Low 1.53
Debt To Equity 72.098
Display Name CEL-SCI
Dividend Date 1,497,484,800
Earnings Timestamp End 1,770,903,000
Earnings Timestamp Start 1,770,903,000
Ebitda -20,257,388
Ebitda Margins 0.0
Enterprise To Ebitda -1.422
Enterprise Value 28,802,536
Eps Current Year -3.07
Eps Forward -6.38
Eps Trailing Twelve Months -1.65
Esg Populated 0
Ex Dividend Date 841,190,400
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.2964
Fifty Day Average Change 0.2636
Fifty Day Average Change Percent 0.2033323
Fifty Two Week Change Percent -86.84211
Fifty Two Week High 12.68
Fifty Two Week High Change -11.120001
Fifty Two Week High Change Percent -0.87697166
Fifty Two Week Low 0.89
Fifty Two Week Low Change 0.66999996
Fifty Two Week Low Change Percent 0.7528089
Fifty Two Week Range 0.89 - 12.68
Financial Currency USD
First Trade Date Milliseconds 439,741,800,000
Float Shares 16,928,521
Forward Eps -6.38
Forward P E -0.2445141
Free Cashflow -8,914,773
Full Exchange Name NYSE American
Fullday Change -0.0400001
Fullday Change Percent -2.50001
Fullday Price 1.625
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,785,542,400
Gross Margins 0.0
Gross Profits -14,796,786
Has Pre Post Market Data 1
Held Percent Insiders 0.06837
Held Percent Institutions 0.11517999
Implied Shares Outstanding 17,588,987
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,759,190,400
Last Split Date 1,747,699,200
Last Split Factor 1:30
Long Business Summary CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Long Name CEL-SCI Corporation
Market us_market
Market Cap 27,438,820
Market State CLOSED
Max Age 86,400
Message Board Id finmb_258746
Most Recent Quarter 1,782,777,600
Net Income To Common -22,703,622
Next Fiscal Year End 1,790,726,400
Non Diluted Market Cap 28,142,379
Number Of Analyst Opinions 2
Open 1.61
Operating Cashflow -16,746,243
Operating Margins 0.0
Overall Risk 9
Payout Ratio 0.0
Peg Ratio 1.12
Phone 703 506 9460
Post Market Change 0.06500006
Post Market Change Percent 4.1666703
Post Market Price 1.625
Post Market Time 1,787,961,308
Previous Close 1.6
Price Eps Current Year -0.5081433
Price Hint 4
Price To Book 2.5040126
Profit Margins 0.0
Quick Ratio 1.287
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0400001
Regular Market Change Percent -2.50001
Regular Market Day High 1.61
Regular Market Day Low 1.53
Regular Market Day Range 1.53 - 1.61
Regular Market Open 1.61
Regular Market Previous Close 1.6
Regular Market Price 1.56
Regular Market Time 1,787,947,200
Regular Market Volume 169,408
Return On Assets -0.66816
Return On Equity -2.52533
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 7
Shares Outstanding 17,588,987
Shares Percent Shares Out 0.040599998
Shares Short 714,471
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 718,008
Short Name Cel-Sci Corporation
Short Percent Of Float 0.0419
Short Ratio 2.4
Source Interval 15
State VA
Symbol CVM
Target High Price 15.0
Target Low Price 10.0
Target Mean Price 12.5
Target Median Price 12.5
Total Cash 6,535,186
Total Cash Per Share 0.372
Total Debt 7,898,903
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.65
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 3.4836
Two Hundred Day Average Change -1.9236
Two Hundred Day Average Change Percent -0.5521874
Type Disp Equity
Volume 169,408
Website https://cel-sci.com
Zip 22,182